Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KPTI

Karyopharm Therapeutics Inc

Jun 09 • 04:00PM ET

8.69

+0.19 2.24 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: OABI CAMP CNTX HUMA RNA TENX TNXP UNCY WHWK MIST

| Held by: VTI VXF IWC PRFZ TMED BTEC CHNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-15.09	Insider Own	13.62%	Shs Outstand	22.54M	Perf Week	-5.85%
Market Cap	196.95M	Forward P/E	-	EPS next Y	-3.12	Insider Trans	-0.88%	Shs Float	19.58M	Perf Month	0.58%
Enterprise Value	336.97M	PEG	-	EPS next Q	-1.31	Inst Own	77.12%	Short Float	26.95%	Perf Quarter	5.59%
Income	-194.97M	P/S	1.30	EPS this Y	77.24%	Inst Trans	9.25%	Short Ratio	6.01	Perf Half Y	51.13%
Sales	151.12M	P/B	-	EPS next Y	23.53%	ROA	-150.48%	Short Interest	5.28M	Perf YTD	18.07%
Book/sh	-11.78	P/C	2.17	EPS next 5Y	55.85%	ROE	-	52W High	10.99 -20.93%	Perf Year	106.41%
Cash/sh	4.01	P/FCF	-	EPS past 3/5Y	16.03% 15.19%	ROIC	-	52W Low	3.65 138.06%	Perf 3Y	-73.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.39% 6.21%	Gross Margin	95.88%	Volatility	9.04% 9.63%	Perf 5Y	-94.22%
Dividend TTM	-	EV/Sales	2.23	EPS Y/Y TTM	-102.63%	Oper. Margin	-55.73%	ATR (14)	0.74	Perf 10Y	-93.65%
Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	6.33%	Profit Margin	-129.02%	RSI (14)	50.02	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.08	EPS Q/Q	55.38%	SMA20	0.64%	Beta	0.83	Target Price	15.00
Payout	-	Debt/Eq	-	Sales Q/Q	16.83%	SMA50	4.29%	Rel Volume	0.37	Prev Close	8.50
Employees	228	LT Debt/Eq	-	Earnings	May 14 BMO	SMA200	20.70%	Avg Volume	878.40K	Price	8.69
IPO	Nov 06, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.50% 11.68%	Trades		Volume	324,139	Change	2.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)